Xcout Intel
Albatroz Therapeutics
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Subscribe to see Albatroz Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Albatroz Therapeutics at a glance
Albatroz Therapeutics is a drug discovery company headquartered in Singapore. Its most recent funding round, Seed, raised $3M in April 2023. Xcout tracks 3 named people at Albatroz Therapeutics, including Christopher Tan (CFO).
Albatroz Therapeutics leadership
- Christopher TanCFO
- Frederic BardCEO & Scientific Co-Founder
- Guy HeathersCBO & Business Co-Founder
Albatroz Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Albatroz Therapeutics competitors
A few of Albatroz Therapeutics's closest competitors — see the full list of competitors and alternatives →
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Diagonal Therapeutics is a biotechnology company headquartered in Watertown, Massachusetts, pioneering disease-modifying clustering antibody therapeutics to target the root causes of devastating diseases.
Get Albatroz Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Albatroz Therapeutics in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access